z-logo
Premium
Transient transfection of epidermal growth factor receptor gene into MCF7 breast ductal carcinoma cell line
Author(s) -
Alokail Majed S.
Publication year - 2004
Publication title -
cell biochemistry and function
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 61
eISSN - 1099-0844
pISSN - 0263-6484
DOI - 10.1002/cbf.1186
Subject(s) - transfection , epidermal growth factor receptor , cancer research , epidermal growth factor , cell culture , breast carcinoma , gene , ductal carcinoma , receptor , carcinoma , biology , chemistry , breast cancer , medicine , cancer , genetics
Epidermal growth factor receptor (EGFR) is activated by autocrine growth factors in many types of tumours, including breast tumours. This receptor has been linked to a poor prognosis in breast cancer and may promote proliferation, migration, invasion, and cell survival as well as inhibition of apoptosis. Human breast ductal carcinoma MCF7 cells were transfected using FuGENE™ 6 with 1 μg of pcDNA3‐EGFR containing the full‐length human EGFR promoter or 1 μg of the vectors alone (pcDNA3). The transfected cells were transferred into a 25‐cm 2 flask containing growth medium and G418. Confluent cultures were lysed, total protein levels measured and electrophoresed. The electrophoresed samples were transferred to nitrocellulose and incubated overnight at 4°C with either anti‐EGFR or anti‐phospho‐ERK and immunoreactive bands were visualized using HRP‐linked secondary antibody. We created a model system of EGFR overexpression in MCF7 clones with stably transfected pcDNA3/EGFR plasmid. These cells have been shown to promote substantial phosphorylation of both ERK1 and ERK2. The high level of EGFR and ERK1/2 phosphorylation was not seen in the pcDNA3 vector control cells or in non‐transfected cells. In this article we describe successful transient transfection experiments on MCF7 cells using the FuGENE™ 6 Transfection Reagent. The overexpression of EGFR could be a mediated stress response and a survival signal that involves ERK1 and ERK2 phosphorylation. Copyright © 2004 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom